Mitchell Jones - Nov 21, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Signature
/s/ Mitchell Jones
Stock symbol
PALI
Transactions as of
Nov 21, 2023
Transactions value $
$0
Form type
4
Date filed
11/24/2023, 04:00 PM
Previous filing
Nov 8, 2023
Next filing
May 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Award $0 +28K $0.00 28K Nov 21, 2023 Common Stock 28K Direct F1, F2, F3, F4
transaction PALI Common Stock Options Award $0 +33.2K $0.00 33.2K Nov 21, 2023 Common Stock 33.2K $0.59 Direct F1, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended ("Plan"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F3 The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024.
F4 N/A.
F5 Each option represents the right to purchase one share of common stock at the exercise price.
F6 The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date.